Haoxi Health Technology (NASDAQ:HAO – Get Free Report) was upgraded by Wall Street Zen to a “hold” rating in a report issued on Saturday.
Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Haoxi Health Technology in a research note on Friday, July 17th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.
Get Our Latest Analysis on Haoxi Health Technology
Haoxi Health Technology Stock Performance
Haoxi Health Technology Company Profile
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.
Read More
- Five stocks we like better than Haoxi Health Technology
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Haoxi Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haoxi Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.
